Merck Isomorphic Labs Collaboration: AI Design Deal Targets One Undisclosed Cancer Target
Merck taps Isomorphic Labs to design small molecules against one strategic cancer target. Deal terms, the co-funding twist and what it means for AI drug discovery.
